Take a look at the number of new medications created in the whole of Europe and then look at the same for the U.S., in any of the last ten years, it may vary due to the pandemic. We simply provide more, newer, usually better medications. Drug manufactures are also the only business that regularly puts 20% of their total take into research for new drugs.

It just seems foolish to me, to kill the golden goose that produces new and needed medications on a regular basis. For those exceedingly rare diseases, there is the orphan drug act, for those diseases that will never, hopefully, have enough of a population to make it profitable to create a drug for them.